TRG035(Toregem Bio)

N/A

Report date: 2022/11/11 09:33:10
First In Class

Base Information

Drug NameTRG035(Toregem Bio)
Drug Alias NameTRG035
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Sclerostin domain-containing protein 1
TargetsSclerostin domain-containing protein 1
Therapy Area/IndicationsAnodontia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAnodontia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A